Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 3
1991 1
1992 2
1993 2
1994 1
1995 3
1996 2
1997 3
1998 5
1999 6
2000 4
2001 5
2002 4
2003 9
2004 9
2005 7
2006 7
2007 6
2008 2
2009 8
2010 8
2011 9
2012 8
2013 4
2014 5
2015 5
2016 3
2017 9
2018 9
2019 8
2020 20
2021 26
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

189 results
Results by year
Filters applied: . Clear all
Page 1
Deployment of convalescent plasma for the prevention and treatment of COVID-19.
Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP, Pekosz A, Lau B, Wesolowski A, Katz L, Shan H, Auwaerter PG, Thomas D, Sullivan DJ, Paneth N, Gehrie E, Spitalnik S, Hod EA, Pollack L, Nicholson WT, Pirofski LA, Bailey JA, Tobian AA. Bloch EM, et al. Among authors: pirofski la. J Clin Invest. 2020 Jun 1;130(6):2757-2765. doi: 10.1172/JCI138745. J Clin Invest. 2020. PMID: 32254064 Free PMC article. Review.
Neutralizing Antibody LY-CoV555 for Outpatient Covid-19.
Casadevall A, Joyner MJ, Pirofski LA. Casadevall A, et al. Among authors: pirofski la. N Engl J Med. 2021 Jan 14;384(2):189. doi: 10.1056/NEJMc2033787. Epub 2020 Dec 30. N Engl J Med. 2021. PMID: 33378610 No abstract available.
The convalescent sera option for containing COVID-19.
Casadevall A, Pirofski LA. Casadevall A, et al. Among authors: pirofski la. J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003. J Clin Invest. 2020. PMID: 32167489 Free PMC article. No abstract available.
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.
Dieterle ME, Haslwanter D, Bortz RH 3rd, Wirchnianski AS, Lasso G, Vergnolle O, Abbasi SA, Fels JM, Laudermilch E, Florez C, Mengotto A, Kimmel D, Malonis RJ, Georgiev G, Quiroz J, Barnhill J, Pirofski LA, Daily JP, Dye JM, Lai JR, Herbert AS, Chandran K, Jangra RK. Dieterle ME, et al. Among authors: pirofski la. Cell Host Microbe. 2020 Sep 9;28(3):486-496.e6. doi: 10.1016/j.chom.2020.06.020. Epub 2020 Jul 3. Cell Host Microbe. 2020. PMID: 32738193 Free PMC article.
Virulence profile: Liise-anne Pirofski.
Pirofski LA. Pirofski LA. Virulence. 2018 Jan 1;9(1):275-277. doi: 10.1080/21505594.2017.1382277. Epub 2017 Nov 10. Virulence. 2018. PMID: 28956699 Free PMC article. No abstract available.
The state of latency in microbial pathogenesis.
Pirofski LA, Casadevall A. Pirofski LA, et al. J Clin Invest. 2020 Sep 1;130(9):4525-4531. doi: 10.1172/JCI136221. J Clin Invest. 2020. PMID: 32804154 Free PMC article. Review.
The Assessment of Convalescent Plasma Efficacy against COVID-19.
Casadevall A, Grossman BJ, Henderson JP, Joyner MJ, Shoham S, Pirofski LA, Paneth N. Casadevall A, et al. Among authors: pirofski la. Med (N Y). 2020 Dec 18;1(1):66-77. doi: 10.1016/j.medj.2020.11.002. Med (N Y). 2020. PMID: 33363284 Free PMC article. Review.
Benefits and Costs of Animal Virulence for Microbes.
Casadevall A, Pirofski LA. Casadevall A, et al. Among authors: pirofski la. mBio. 2019 Jun 4;10(3):e00863-19. doi: 10.1128/mBio.00863-19. mBio. 2019. PMID: 31164465 Free PMC article. Review.
What Is a Host? Attributes of Individual Susceptibility.
Casadevall A, Pirofski LA. Casadevall A, et al. Among authors: pirofski la. Infect Immun. 2018 Jan 22;86(2):e00636-17. doi: 10.1128/IAI.00636-17. Print 2018 Feb. Infect Immun. 2018. PMID: 29084893 Free PMC article. Review.
189 results